ZHIFEI’S STOCKS PERFORMANCE MASTERLY IN SECURING APPROVAL FOR COVID-19 VACCINE

• In the battle against the coronavirus, a vaccine trial and error is almost always a boost for pharma stocks.
• That being the reason for Chongqing Zhifei Biological Products Co. shares having peaked past the 80% marker since the vaccine maker revealed at the end of June that China’s drug regulator approved clinical human testing of a Covid-19 vaccine.

With a 256% stupefying perfo....